Cite
HARVARD Citation
So, H. et al. (2022). Immunogenicity and safety of inactivated and mRNA COVID-19 vaccines in patients with systemic lupus erythematosus. Therapeutic advances in musculoskeletal disease. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
So, H. et al. (2022). Immunogenicity and safety of inactivated and mRNA COVID-19 vaccines in patients with systemic lupus erythematosus. Therapeutic advances in musculoskeletal disease. p. . [Online].